Advertisement

Enantiomeric composition of urinary salsolinol in Parkinsonian patients after Madopar

  • P. Dostert
  • M. Strolin Benedetti
  • G. Dordain
  • D. Vernay
Article

Summary

Urinary salsolinol output had been shown to be lower in Parkinsonian patients than in controls and to increase largely after L-dopa therapy. It had also been established that the R enantiomer of salsolinol is either the predominant or the sole enantiomer present in the urine of healthy subjects.

When Madopar was administered to Parkinsonians, the enantiomeric composition of urinary salsolinol showed an S/R ratio around 1. Considering brain and plasma concentrations in dopamine, acetaldehyde and pyruvate, it is suggested that, under physiological conditions, urinary salsolinol should have a central origin in humans. Conversely, urinary salsolinol in Madopar-treated Parkinsonian patients might be predominantly formed at the periphery.

Keywords

R and S salsolinol Parkinsonian patients L-dopa pyruvate acetaldehyde dopamine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brossi A (1982) Mammalian TIQ's: products of condensation with aldehydes or pyruvic acids? Prog Clin Biol Res 90: 123–133Google Scholar
  2. Claustre J, Serusclat P, Peyrin L (1983) Glucuronide and sulfate catecholamine conjugates in rat and human plasma. J Neural Transm 56: 265–278CrossRefPubMedGoogle Scholar
  3. Collins MA (1985) Alkaloids condensation products as biochemical indicators in alcoholism. In: Chang N, Chao H (eds) Early identification of alcohol abuse. (NIAAA monography, vol 17, pp 255–267)Google Scholar
  4. Collins MA, Cheng BY (1988) Oxidative decarboxylation of salsolinol-1-carboxylic acid to 1,2-dehydrosalsolinol: evidence for exclusive catalysis by particulate factors in rat kidney. Arch Biochem Biophys 263: 86–95CrossRefPubMedGoogle Scholar
  5. Collins MA, Dahl K, Nijm WP, Major LF (1982) Evidence for homologous families of dopamine and serotonin condensation products in cerebrospinal fluids from monkeys. Soc Neurosci Abstr 8: 277Google Scholar
  6. Dannecker JR, Shaskan EG, Philips M (1981) A new highly sensitive assay for breath acetaldehyde: detection of endogenous levels in humans. Anal Biochem 114: 1–7CrossRefPubMedGoogle Scholar
  7. Da Prada M, Zürcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 19: 1161–1174CrossRefPubMedGoogle Scholar
  8. Dordain G, Dostert P, Strolin Benedetti M, Rovei V (1984) Tetrahydroisoquinoline derivatives and Parkinsonism. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Prospects for therapy with reversible inhibitors. Academic Press, London, pp 417–426Google Scholar
  9. Dostert P, Strolin Benedetti M, Dedieu M (1987a) Is Salsolinol as a racemic mixture in human urine or does an enantiomer predominates? Pharmacol Toxicol 60 [Suppl 1]: 12Google Scholar
  10. Dostert P, Strolin Benedetti M, Dedieu M (1987b) Ratio of enantiomers of Salsolinol in human urine. Pharmacol Toxicol 60 [Suppl 1]: 13Google Scholar
  11. Dostert P, Strolin Benedetti M, Dordain G (1988) Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases. J Neural Transm 74: 61–74CrossRefPubMedGoogle Scholar
  12. Elchisak MA (1983) Distribution of free and conjugated dopamine in human caudate nucleus, hypothalamus, and kidney. J Neurochem 41: 893–896PubMedGoogle Scholar
  13. Gal J, Desai DM, Bloedow DC (1986) (S)-1-(naphthyl)ethyl isothiocyanate: a new chiral derivatizing agent in liquid chromatography. In: 10th international symposium on column liquid chromatography, San Francisco, May 18–23 (book of abstracts, p 406)Google Scholar
  14. Gottfries CG, Kjällquist A, Ponten U, Ross BE, Sundbärg G (1974) Cerebrospinal fluid pH and monoamine and glucolytic metabolites in Alzheimer's disease. Br J Psychiat 124: 280–287Google Scholar
  15. Hansen JL, Freier EF (1978) Direct assays of lactate, pyruvate, β-hydroxybutyrate, and acetoacetate with a centrifugal analyser. Clin Chem 24: 475–479PubMedGoogle Scholar
  16. Hardy JA, Wester P, Backstrom I, Gottfries J, Oreland L, Stenstrom A, Windblad B (1987) The regional distribution of dopamine and serotonine uptake and transmitter concentrations in the human brain. Neurochem Int 10: 445–450CrossRefGoogle Scholar
  17. Hornykiewicz O, Kish SJ (1986) Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45: 19–34Google Scholar
  18. Johnson GA, Baker CA, Smith RT (1980) Radioenzymatic assay of sulfate conjugates of catecholamines and dopa in plasma. Life Sci 26: 1591–1598PubMedGoogle Scholar
  19. Kapadia GJ, Subba Rao G, Leete E, Fayez MBE, Vaishnav YN, Fales HM (1970) On the origin of carbon 1 in tetrahydroisoquinoline alkaloids. J Am Chem Soc 92: 6943–6951.PubMedGoogle Scholar
  20. Kopin IJ (1985) Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37: 333–364PubMedGoogle Scholar
  21. Kienzl E, Eichinger K, Jellinger K, Riederer P (1988) Excretion patterns of dopamine sulfoconjugates in patients with Parkinson's disease. In: 9th international symposium on Parkinson's disease, Jerusalem, June 5–9 (book of abstracts, p 25)Google Scholar
  22. Kuruma J, Bartholini G, Tissot R, Plettscher A (1972) Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats. J Pharm Pharmacol 24: 289–294PubMedGoogle Scholar
  23. Myers WD, Ng KT, Singer G, Smythe GA, Duncan MW (1985) Dopamine and salsolinol levels in rat hypothalami and striatum after schedule-induced self-injection of ethanol and acetaldehyde. Brain Res 358: 122–128PubMedGoogle Scholar
  24. Pianezzola E, Bellotti V, Fontana E, Gal J, Desai DM, Moro E (in press) Determination of the enantiomeric composition of salsolinol by HPLC with electrochemical detection. J Chromatogr Biomed ApplGoogle Scholar
  25. Renskers KJ, Feor KD, Roth JA (1980) Sulfation of dopamine and other biogenic amines by human brain phenol sulfotransferase. J Neurochem 34: 1362–1368PubMedGoogle Scholar
  26. Rinne UK (1980) Levodopa in combination with an extracerebral decarboxylase inhibitor. In: Rinne UK, Klinger M, Stamm G (eds) Parkinson's disease—Current progress, problems and management. Elsevier, North-Holland Biomedical Press, pp 323–334Google Scholar
  27. Rivett AJ, Eddy BJ, Roth JA (1982) Contribution of sulfate conjugation, deamination, and 0-methylation to metabolism of dopamine and norepinephrine in human brain. J Neurochem 39: 1009–1016PubMedGoogle Scholar
  28. Robbins JH (1968) Possible alkaloid formation in alcoholism and other diseases. Clin Res 16: 554Google Scholar
  29. Rossor MN, Watkins J, Brown MJ, Reid JL, Dollery CT (1980) Plasma levodopa, dopamine and therapeutic response following levodopa therapy of Parkinsonian patients. J Neurol Sci 46: 385–392PubMedGoogle Scholar
  30. Rueffer M, El-Shagi H, Nagakura N, Zenk MH (1981) (S)-Norlaudasonoline synthase: the first enzyme in the benzylisoquinoline biosynthetic pathway. FEBS Lett 129: 5–9Google Scholar
  31. Sandler M, Bonham Carter S, Hunter KR, Stern GM (1973) Tetrahydroisoquinoline alkaloids: in vivo metabolites of L-dopa in man. Nature 241: 439–443PubMedGoogle Scholar
  32. Schöpf C, Bayerle H (1934) Zur Frage der Biogenese der Isochinolin-alkaloide—Die Synthese des 1-Methyl-6,7-dioxy-1,2,3,4-tetrahydro-isochinolins unter physiologischen Bedingungen. Justus Liebigs Ann Chem 513: 190–202Google Scholar
  33. Shah RJ, Vaghani DD, Merchant JR (1961) Heterocyclic compounds. I. Synthesis of some isoquinoline derivatives. J Org Chem 26: 3533–3534Google Scholar
  34. Sippel HW (1974) The acetaldehyde content in rat brain during ethanol metabolism. J Neurochem 23: 451–452PubMedGoogle Scholar
  35. Sjöquist B, Ljungquist C (1985) Identification and quantification of 1-carboxysalsolinol and salsolinol in biological samples by gas chromatography-mass spectrometry. J Chromatogr Biomed Appl 343: 1–8Google Scholar
  36. Smythe GA, Duncan MW (1985) Precise GC/MS assays for salsolinol and tetrahydropapaveroline: the question of artifacts and dietary sources and the influence of alcohol. Prog Clin Biol Res 183: 77–84PubMedGoogle Scholar
  37. Stowell AR, Lindros KO, Salaspuro MP (1980) Breath and blood acetaldehyde concentrations and their correlation during normal and calcium carbimide-modified ethanol oxidation in man. Biochem Pharmacol 29: 783–787Google Scholar
  38. Strolin Benedetti M, Dostert P, Dedieu M (1986) Ratio of enantiomers of salsolinol in human urine and effect of food. In: 15th CINP congress, Porto Rico, December 14–17 (book of abstracts, p 56)Google Scholar
  39. Strolin Benedetti M, Dostert P, Carminati P (1989a) Influence of food intake on the enantiomeric composition of urinary salsolinol in man. J Neural Transm [GenSect] 78: 43–51Google Scholar
  40. Strolin Benedetti M, Bellotti V, Pianezzola E, Moro E, Carminati P, Dostert P (1989b) Ratio of the R and S enantiomers of salsolinol in food and human urine. J Neural Transm 77: 47–53PubMedGoogle Scholar
  41. Tyce GM (1976) The effect of L-dopa and an inhibitor of peripheral decarboxylation on glucose metabolism in brain. J Neurochem 27: 1397–1403PubMedGoogle Scholar
  42. Ung-Chhun N, Cheng BY, Pronger DA, Serrano P, Chavez B, Fernandez Perez R, Morales J, Collins MA (1985) Alkaloid adducts in human brain: coexistence of 1-carboxylated and noncarboxylated isoquinolines and β-carbolines in alcoholics and nonalcoholics. Prog Clin Biol Res 183: 125–136PubMedGoogle Scholar
  43. Whaley WH, Govindachari TR (1951) The Pictet-Spengler synthesis of tetrahydroisoquinolines and related compounds. In: Organic reactions, vol 6. Wiley, London, pp 151–190Google Scholar
  44. Westcoot JY, Weiner H, Shultz J, Myers RD (1980) In vivo acetaldehyde in the brain of the rat treated with ethanol. Biochem Pharmacol 29: 411–417PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • P. Dostert
    • 1
  • M. Strolin Benedetti
    • 1
  • G. Dordain
    • 2
  • D. Vernay
    • 2
  1. 1.Research and Development-Erbamont GroupFarmitalia Carlo ErbaMilanItaly
  2. 2.Service de NeurologieHôpital NordClermont-FerrandFrance

Personalised recommendations